The DNA demethylating agent 5-aza-2′-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells-Reference-Cited by-同舟云学术

The DNA demethylating agent 5-aza-2′-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells

Published:2010-07 Issue:7 Volume:34 Page:899-905
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Almstedt Maika,Blagitko-Dorfs Nadja,Duque-Afonso Jesús,Karbach Julia,Pfeifer Dietmar,Jäger Elke,Lübbert Michael

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference50 articles.

1. Cellular differentiation, cytidine analogs and DNA methylation;Jones;Cell,1980

2. Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2′-deoxycytidine;Lübbert;Br J Haematol,2001

3. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B;Silverman;J Clin Oncol,2002

4. Inhibition of DNA methylation in L1210 leukemic cells by 5-aza-2′-deoxycytidine as a possible mechanism of chemotherapeutic action;Wilson;Cancer Res,1983

5. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-aza-2′-deoxycytidine (decitabine) treatment;Daskalakis;Blood,2002

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypomethylating Agents are Effective in Treatment for Relapsed Myelofibrosis After Allogeneic Hematopoietic Cell Transplantation;Transplantation and Cellular Therapy;2024-08

2. Decitabine-containing conditioning improved outcomes for children with higher-risk myelodysplastic syndrome undergoing allogeneic hematopoietic stem cell transplantation;Annals of Hematology;2024-02-06

3. Immunotherapy for Ovarian Cancer: Disappointing or Promising?;Molecular Pharmaceutics;2024-01-17

4. Vaccines: a promising therapy for myelodysplastic syndrome;Journal of Hematology & Oncology;2024-01-08

5. Fast proliferating and slowly migrating non‐small cell lung cancer cells are vulnerable to decitabine and retinoic acid combinatorial treatment;International Journal of Cancer;2023-11-10